Illicit drug use by pregnant women infected with HIV

被引:0
|
作者
Melo, Victor Hugo [2 ]
Machahado Botelho, Ana Paula [3 ]
Martins Maia, Marcelle Marie [4 ]
Correa Junior, Mario Dias [1 ]
Pinto, Jorge Andrade [5 ]
机构
[1] Univ Fed Minas Gerais, Fac Med, Dept Ginecol & Obstet, Ave Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Saude Mulher, Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Curso Grad Med, Belo Horizonte, MG, Brazil
[4] Univ Fed Minas Gerais, Grp Pesquisa HIV Materno Infantil, Belo Horizonte, MG, Brazil
[5] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil
来源
关键词
Drug users; Crack cocaine; Pregnancy complications; infectious; HIV infections; Infectious disease transmission; vertical;
D O I
10.1590/SO100-720320140005155
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
PURPOSE: To determine if illicit drug use increases the vertical transmission of HIV, to identify the risk factors involved in mother and child health and the prevalence of illicit drug use among these pregnant women. METHODS: Sixty-four (7.6%) of 845 pregnant women from the metropolitan region of Belo Horizonte, Minas Gerais, Brazil, attended in the service between October 1997 and February 2012 reported the use of illicit drugs. Cases were HIV- positive drug users (n=64) and controls were women who did not use drugs (n=192). Three controls were selected for each case. Several conditions of exposure were considered in the control group such as tobacco use, alcohol use, alcohol and tobacco use, maternal age, educational level, ethnicity, and marital status. Problems during the prenatal period, delivery and postpartum, vertical HIV transmission and neonatal outcomes were also investigated. RESULTS: Univariate analysis showed as significant variables: maternal age, tobacco use, number of prenatal care visits, antiretroviral therapy, mode of infection, and viral load at delivery. Logistic regression revealed as significant variables: maternal age (less than 25 years); tobacco use, and number of prenatal care visits (less than 6). The vertical transmission of HIV was 4,8% (95% CI 1.7-13.3) among drug users and 2,1% (95% CI 0.8-5.2) in the control group, with no statistically significant difference between groups. Neonatal complications were more frequent among drug users, but also with no statistically significant difference between groups. CONCLUSION: The use of illicit drug is frequent during pregnancy among HIV- infected women. The approach to illicit drug use should be routine during prenatal care visits. These women are more discriminated against and tend to deny their habits or do not seek prenatal care. There was no difference in vertical virus transmission between groups, probably indicating adherence to antiretroviral use for antiretroviral therapies during pregnancy.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 50 条
  • [31] The impact of harm reduction on HIV and illicit drug use
    Ti, Lianping
    Kerr, Thomas
    HARM REDUCTION JOURNAL, 2014, 11
  • [32] RECOGNIZING ILLICIT DRUG-USE BY PREGNANT-WOMEN - REPORTS FROM OREGON BIRTH ATTENDANTS
    SLUTSKER, L
    SMITH, R
    HIGGINSON, G
    FLEMING, D
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1993, 83 (01) : 61 - 64
  • [33] The impact of harm reduction on HIV and illicit drug use
    Lianping Ti
    Thomas Kerr
    Harm Reduction Journal, 11
  • [34] METHADONE TREATMENT OR ILLICIT DRUG USE DO NOT AFFECT TRADITIONAL ETHANOL BIOMARKERS AMONG PREGNANT WOMEN
    Bakhireva, L. N.
    Young, B. N.
    Savich, R. D.
    Price, S. Zozaya
    Garcia-Cherino, S.
    Chavez, S.
    Lewis, P. Trujillo
    Savagem, D. D.
    Rayburn, W. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 101A - 101A
  • [35] Type and pattern of illicit drug use and access to health care services for HIV-infected people
    Sohler, Nancy L.
    Wong, Mitchell D.
    Cunningham, William E.
    Cabral, Howard
    Drainoni, Mari-Lynn
    Cunningham, Chinazo O.
    AIDS PATIENT CARE AND STDS, 2007, 21 : S68 - S76
  • [36] Darunavir for use in pregnant women with HIV
    Pope, Robert, Jr.
    Kashuba, Angela
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (12) : 1317 - 1327
  • [37] Resistance to antiretrovirals in HIV-infected pregnant women
    Weinberg, Adriana
    Forster-Harwood, Jeri
    McFarland, Elizabeth J.
    Pappas, Jennifer
    Davies, Jill K.
    Kinzie, Kay
    Barr, Emily A.
    Paul, Suzanne M.
    Salbenblatt, Carol R.
    Soda, Elizabeth
    Vazquez, Anna
    Levin, Myron J.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 45 (01) : 39 - 42
  • [38] Immunological markers in HIV-infected pregnant women
    Newell, ML
    Rudin, C
    Dunn, D
    Peckham, C
    Giaquinto, C
    Ruga, E
    DeRossi, A
    Truscia, D
    GroschWorner, I
    Schafer, A
    Mok, J
    Johnstone, F
    Jiminez, J
    deAlba, C
    OmenacaTeres, F
    GarciaRodriguez, MC
    Bates, I
    deJose, I
    Hawkins, F
    Zapico, RM
    Canosa, CA
    GonzalezMolina, A
    Bonet, FA
    Scherpbier, H
    Boer, K
    Bohlin, AB
    Lindgren, S
    Ehrnst, A
    Anzen, B
    Belfrage, E
    Levy, J
    Alimenti, A
    Barlow, P
    Ferrazin, A
    DeMaria, A
    Gotta, C
    Maritati
    Mur, A
    Puges, MTR
    Coll, O
    Fortuny, C
    Boguna, J
    Caro, MC
    Canet, Y
    Pardi, G
    Ravizza, M
    Semprini, E
    Castagna, C
    Fiore, S
    Guerra, B
    AIDS, 1997, 11 (15) : 1859 - 1865
  • [39] Prevalence of depression in HIV-infected pregnant women
    Levine, AB
    Aaron, E
    Laquinte, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (06) : S97 - S97
  • [40] CARE OF PREGNANT-WOMEN INFECTED WITH HIV - REPLY
    MINKOFF, HL
    DEHOVITZ, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (04): : 272 - 272